These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19566124)

  • 1. A spatial model of tumor-host interaction: application of chemotherapy.
    Hinow P; Gerlee P; McCawley LJ; Quaranta V; Ciobanu M; Wang S; Graham JM; Ayati BP; Claridge J; Swanson KR; Loveless M; Anderson AR
    Math Biosci Eng; 2009 Jul; 6(3):521-46. PubMed ID: 19566124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hybrid model of tumor growth and angiogenesis: In silico experiments.
    Phillips CM; Lima EABF; Woodall RT; Brock A; Yankeelov TE
    PLoS One; 2020; 15(4):e0231137. PubMed ID: 32275674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response.
    Geindreau M; Ghiringhelli F; Bruchard M
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
    Aderhold C; Umbreit C; Faber A; Sauter A; Sommer JU; Birk R; Erben P; Hofheinz RD; Stern-Straeter J; Hörmann K; Schultz JD
    Anticancer Res; 2013 May; 33(5):1951-61. PubMed ID: 23645743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model.
    Wu H; Xin Y; Zhao J; Sun D; Li W; Hu Y; Wang S
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):879-87. PubMed ID: 21290245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.
    Kaliski A; Maggiorella L; Cengel KA; Mathe D; Rouffiac V; Opolon P; Lassau N; Bourhis J; Deutsch E
    Mol Cancer Ther; 2005 Nov; 4(11):1717-28. PubMed ID: 16275993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ang-2-VEGF-A CrossMab, a novel bispecific human IgG1 antibody blocking VEGF-A and Ang-2 functions simultaneously, mediates potent antitumor, antiangiogenic, and antimetastatic efficacy.
    Kienast Y; Klein C; Scheuer W; Raemsch R; Lorenzon E; Bernicke D; Herting F; Yu S; The HH; Martarello L; Gassner C; Stubenrauch KG; Munro K; Augustin HG; Thomas M
    Clin Cancer Res; 2013 Dec; 19(24):6730-40. PubMed ID: 24097868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Avastin potentiates chemotherapeutic drugs: action and reaction in antiangiogenic therapy.
    Blagosklonny MV
    Cancer Biol Ther; 2005 Dec; 4(12):1307-10. PubMed ID: 16322683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player.
    Benelli R; Monteghirfo S; Balbi C; Barboro P; Ferrari N
    Int J Cancer; 2009 Jun; 124(12):2989-96. PubMed ID: 19319982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapy.
    Shah DK; Shin BS; Veith J; Tóth K; Bernacki RJ; Balthasar JP
    J Pharmacol Exp Ther; 2009 May; 329(2):580-91. PubMed ID: 19233938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of Angiogenesis in Cancer Therapy - Synthesis and Biological Activity.
    Gensicka M; Głowacka A; Dzierzbicka K; Cholewinski G
    Curr Med Chem; 2015; 22(33):3830-47. PubMed ID: 26337104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microenvironment: a mechanical force link.
    Huang B
    Sci China Life Sci; 2015 Feb; 58(2):202-4. PubMed ID: 25563980
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy.
    Veeravagu A; Hsu AR; Cai W; Hou LC; Tse VC; Chen X
    Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):59-71. PubMed ID: 18221053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer.
    Fersis N; Smyczek-Gargya B; Armeanu S; Gagulic E; Pantic L; Relakis K; Friedrich M; Wallwiener D
    Eur J Gynaecol Oncol; 2004; 25(1):45-50. PubMed ID: 15053061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts.
    Roland CL; Dineen SP; Lynn KD; Sullivan LA; Dellinger MT; Sadegh L; Sullivan JP; Shames DS; Brekken RA
    Mol Cancer Ther; 2009 Jul; 8(7):1761-71. PubMed ID: 19567820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center.
    Hotchkiss KA; Ashton AW; Mahmood R; Russell RG; Sparano JA; Schwartz EL
    Mol Cancer Ther; 2002 Nov; 1(13):1191-200. PubMed ID: 12479700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies.
    Finley SD; Engel-Stefanini MO; Imoukhuede PI; Popel AS
    BMC Syst Biol; 2011 Nov; 5():193. PubMed ID: 22104283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
    Avramis IA; Kwock R; Avramis VI
    Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of vascular endothelial growth factor in acute rejection reaction following liver transplantation.
    Zhou TB; Yang GS
    Transpl Immunol; 2011 Dec; 25(4):207-9. PubMed ID: 21856421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.